#CBD Nutraceuticals Market Report

[market-insider]

Exploring the Cannabidiol Nutraceuticals Market: Detailed Insights on Size, Share, and Growth Potential

The global CBD nutraceuticals market is projected to reach USD 17.4 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to exhibit a CAGR of 18.8% during the forecast period. Introduction of the 2018 Farm Bill that legalized hemp cultivation and hemp-derived products in U.S., rising consumer preference for plant-based ingredients in dietary supplements, and awareness regarding the health benefits of cannabidiol are some of the factors powering the market growth. However, the easy availability of alternative products is obstructing market growth.

Further key findings from the report suggest

In 2018, CBD tinctures dominated the Cannabidiol nutraceuticals market with a revenue share of 42.6%, due to the higher bioavailability than other product types

The online sales channel is projected to witness the fastest growth rate over the forecast period. Many companies are opting for this channel, as it is a faster way to reach the target audience

Some of the major market players are Medical Marijuana Inc.; CV Sciences Inc.; CHARLOTTE’S WEB; Irwin Naturals; and MGC Pharma

For More Details or Sample Copy please visit link @: Cannabidiol Nutraceuticals Market

CBD tinctures dominated the global Cannabidiol (CBD) nutraceuticals market in 2018, with a revenue share of 42.6%. Increasing acceptance of cannabidiol for health and wellness purposes coupled with high bioavailability of tinctures when administered sublingually are the major factors responsible for this large market share. On the other hand, capsules and soft gels are anticipated to be the fastest-growing product type over the forecast period, as they are travel-friendly and convenient to carry in public places. However, many consumers dislike the raw taste and texture of cannabidiol and so they are switching towards capsules and softgels.

Based on the sales channel, retail store segment dominated the CBD (Cannabidiol) nutraceuticals market in 2018, as consumers prefer retail stores for buying dietary supplements due to attractive pricing. On the other hand, the online sales channel is expected to expand at the fastest CAGR over the forecast period owing to the rise in the preference for online shopping. Furthermore, the new entrants in the CBD nutraceuticals space, find online sales channel a much economical alternative than a retail storefront.

Top Companies in the Cannabidiol Nutraceuticals Market

CV Sciences, Inc.

Medical Marijuana Inc.

CHARLOTTE’S WEB

MGC Pharma

ENDOCA

Isodiol

Elixinol

Diamond CBD

Irwin Naturals

[industryforecastnews]

CBD Consumer Health Market Size To Reach $61.17Bn By 2030

CBD Consumer Health Market Growth & Trends

The global CBD consumer health market size is anticipated to reach USD 61.17 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 18.1% from 2023 to 2030. The growing adoption of cannabidiol (CBD) as a consumer health product due to increasing awareness about the health benefits of CBD and rise in the number of countries legalizing these products are the key factors driving the growth. Furthermore, the changing buyer perception and attitude toward cannabidiol products is an important factor bolstering the revenue growth.

Based on product type, nutraceuticals dominated the market with a revenue share of 62.4% in 2019. Rising awareness regarding cannabidiol, changing user preferences from chemical-based ingredients to organic ingredients in dietary supplements, and favorable government initiatives for hemp-derived cannabidiol are the key factors driving the growth. The segment is anticipated to witness the fastest CAGR during the forecast period, owing to an increase in the consumption of CBD-based nutraceutical products in health and wellness, sports nutrition, weight management, and other fields.

Based on distribution channels, retail pharmacies dominated the market for cannabidiol consumer health in 2019. An increase in the number of companies selling their products via retail pharmacies is fueling the growth of the segment. However, the online stores segment is anticipated to witness fastest growth over the forecast period. This can be attributed to the increase in penetration of e-commerce, rising demand for CBD-infused products, preference of consumers for buying CBD online, and easy availability of these products in emerging markets.

North America dominated the market in 2019, with a revenue share of 59.8%. The growing awareness about the medical benefits of CBD among consumers has resulted in greater sales of online and retail sales in the region. On the other hand, Europe is expected to be the fastest-growing region, owing to an increase in consumption, rising awareness, positive attitudes regarding CBD products, and strategic investments by major companies in the region.

Request a free sample copy: https://www.grandviewresearch.com/industry-analysis/cannabidiol-consumer-health-market 

CBD Consumer Health Market Report Highlights

Nutraceuticals dominated the market in 2022 with a revenue share of 60%, owing to the changing consumer preferences from chemical-based ingredients to organic and herbal ingredients in dietary supplements

Online stores is anticipated to be the fastest-growing distribution channel segment over the forecast period, owing to the increase in penetration of e-commerce and the rising number of players offering their products online

North America dominated the CBD consumer health market for cannabidiol consumer health products, with a revenue share of around 70% in 2022.

CBD Consumer Health Market Segmentation

Grand View Research has segmented the global CBD consumer health market based on product type, distribution channel, and region:

CBD Consumer Health Product Type Outlook (Revenue, USD Million, 2018 - 2030)

Medical OTC Products

CBD Analgesic Products

CBD Dermatology Products

CBD Mental Health Products

CBD Sleeping Aids Products

Other OTC Products

Nutraceuticals

CBD Vitamins and Dietary Supplements (VDS)

CBD Sports Nutrition

CBD Weight Management and Wellbeing

CBD Consumer Health Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

Online Stores

Retail Stores

Retail Pharmacies

CBD Consumer Health Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

UK

Germany

France

Italy

Spain

Sweden

Norway

Denmark

Asia Pacific

China

Australia

Thailand

Japan

India

South Korea

Latin America

Brazil

Argentina

Mexico

Middle East & Africa (MEA)

Saudi Arabia

South Africa

UAE

Kuwait

List of Key Players in the Cannabidiol (CBD) Consumer Health Market

Elixinol Global Limited

ENDOCA

NuLeaf Naturals LLC

Kazmira

Charlotte's Web

Joy Organics

Lord Jones

Medical Marijuana Inc.

CV Sciences Inc.

Isodiol International Inc.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/cannabidiol-consumer-health-market 

[adityarana1687-blog]

Nutraceuticals Market Is Expected To Grow Swiftly By 2030

The global nutraceuticals market size is projected to reach USD 599.71 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 9.6% from 2024 to 2030. Rising awareness regarding calorie reduction and weight loss in the major markets including the U.S., China, and India is expected to promote the application of the health and wellness segment and thus, in turn, will have a substantial impact on the industry.

Nutraceuticals are products that provide health advantages and additional nutrition to the human body. It comprises fortified nutrients, such as taurine, CoQ10, omega-3, calcium, zinc, and antioxidants, that develop the complete health of consumers. These nutrients further benefit in averting medical conditions such as hypertension, diabetes, heart diseases, and allergies. As nutraceuticals develop the digestive and immune systems and enhance the cognitive behavior of consumers, their demand is witnessing a surge at the global level.

The increasing trend among consumers to alter dietary habits is likely to boost the demand for nutraceuticals. The consumer belief that improper diet results in an increase in the costs of pharmaceuticals is anticipated to boost the demand for nutraceuticals. This would also help the government as it would result in lesser expenditure on healthcare and low social security costs.

A rise in disposable income, increasing consumer awareness concerning health issues, and rapid urbanization are likely to boost the market growth over the forecast years. A positive outlook towards medical nutrition owing to the high prevalence of weight management programs, along with cardiovascular diseases, is anticipated to propel the product demand.

The rise and evolution of wellness-focused diets such as keto and paleo are driving food producers to cater their products in this direction. Functional food products such as probiotics and omega-3 are highly used in yogurt and fish oils to reduce the risk of cardiovascular diseases and develop the quality of intestinal microflora, which is further projected to fuel the growth of the functional food segment over the coming years.

Request a free sample copy or view report summary: Nutraceuticals Market Report

Nutraceuticals Market Report Highlights

Based on ingredient, in 2023, probiotics held a dominant position in the market; with a share of 27.7% owing to the majority of food manufacturing companies using probiotics as a primary ingredient to provide better nourishment and reduce health problems caused by harmful bacteria

The vitamins segment captured a significant market share in 2023. The segment is expected to witness significant growth in the coming years

In terms of product, the functional foods segment dominated the market with a revenue share of 37.65% in 2023. Rising healthcare costs, coupled with the increasing geriatric population across the world, are anticipated to assist the segment growth over the forecast period

North America held the largest revenue share of over 34.90% in 2023. The growing health concerns amongst consumers and increasing awareness regarding nutraceuticals are likely to be the major drivers of the North America market.

The market represents a highly competitive landscape. Key market players dominate the market space and have been focusing on various strategic initiatives including mergers & acquisitions, product innovation, and portfolio expansion

Nutraceuticals Market Segmentation

Grand View Research has segmented the global nutraceuticals market based on ingredient, product, application, and region:

Nutraceuticals Ingredient Outlook (Revenue, USD Million, 2018 - 2030)

Aloe vera

Amino acids

Botanical Ingredients

Ashwagandha

Curcumin

Ginseng

Hemp

Others

Cannabidiol (CBD)

Carbohydrates

Carnitine

Food Color

Carotenoids

Astaxanthin

Lutein

Lycopene

Other carotenoids (Zeaxanthin, Betacarotene)

Spirulina

Collagen

Colostrum

Cultures and fermentation starters

Dairy ingredients

Emulsifiers

Enzymes

Essential oils

Fat replacers

Fats and oils

Fibers

Flavors

Fruit and vegetable products

Glucosamine / Chondroitin

Isoflavones

Juices and concentrates

Krill

Lipids / Fatty Acids

Marine ingredients

Minerals

Calcium

Iron

Magnesium

Selenium

Others

Omega-3s

Marine Derived

Plant-derived

Prebiotics

Probiotics

Proteins

Sweeteners

Stevia

Monkfruit

Others (Honey, sucrose, fructose, etc.)

Vitamins

Vitamin A

Vitamin B

Vitamin C

Vitamin D

Vitamin E

Vitamin K

Whey proteins

Other

Nutraceuticals Product Outlook (Revenue, USD Million, 2018 - 2030)

Dietary supplements

Functional foods

Functional beverages

Nutraceuticals Application Outlook (Revenue, USD Million, 2018 - 2030)

Allergy & intolerance

Animal nutrition

Healthy ageing

Bone & joint health

Cancer prevention

Children's health

Cognitive health

Diabetes

Digestive / Gut health

Energy & endurance

Eye health

Heart health

Immune system

Infant health

Inflammation

Maternal health

Men's health

Nutricosmetics

Oral care

Personalized nutrition

Post Pregnancy and reproductive health

Sexual health

Skin health

Sports nutrition

Weight management & satiety

Women's health

Other

Nutraceuticals Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

UK

Spain

The Netherlands

Asia Pacific

China

Japan

India

Australia & New Zealand

South Korea

Central & South America

Brazil

Argentina

Middle East & Africa

UAE

South Africa

List of Key Players in the Nutraceuticals Market

DSM

Amway

Pfizer Inc.

Nestle

The Kraft Heinz Company

The Hain Celestial Group, Inc.

Nature's Bounty

General Mills Inc.

Danone

Tyson Foods

[ananya5400]

Gummy Supplement MarketProjected to Garner Significant Revenues by 2028

According to a research report "Gummy Supplements Market by Type (Vitamin Gummies, Omega Fatty Acid Gummies, Collagen Gummies, CBD Gummies), Starch Ingredient (Supplements With Starch, Starchless Systems), Distribution Channel, End User, Functionality Region - Global Forecast to 2028" published by MarketsandMarkets, the global Gummy supplement market is projected to reach USD 48.5 billion by 2028 from USD 24.6 billion by 2023, at a CAGR of 14.5% during the forecast period in terms of value. The World Health Organization (WHO) estimates that more than two billion people worldwide suffer from micronutrient insufficiency. Iron, vitamin A, and iodine deficiencies are the most prevalent worldwide, particularly in youngsters and pregnant women. Micronutrient deficits are disproportionately prevalent in low- and middle-income counties. Micronutrient deficiencies can induce evident and serious health issues, but they can also produce less clinically noticeable decreases in energy, mental clarity, and overall capacity. This may result in poorer academic performance, decreased productivity at work, and a higher chance of contracting other illnesses and medical disorders. A lot of these inadequacies can be avoided by taking supplements. Thus, consumers are gradually adopting gummy supplements which provide the required number of vitamins, minerals, and other micronutrients in a convenient and tasteful form.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39376426

Vitamin gummies segment is anticipated to have the largest share among gummy types in 2023

The global market for gummy vitamins is currently experiencing tremendous growth. Gummy vitamins typically have delicious fruity flavors and all the necessary micronutrients. Therefore, a lot of individuals choose gummy vitamins over conventional vitamins, especially kids and elder people who have problems swallowing tablets. In the upcoming years, the nutraceutical business is expected to see a significant increase in sales of vitamin gummies. Working-class consumers who seek to balance health factors like folic acid, metabolic health, and glycemic index in an effort to address problems like bone strength, immunity, and vitamin deficiencies will also contribute significantly in the expansion of the gummy supplements market.

The kids segment is projected to grow at the fastest rate among all the other end-users in the Gummy Supplements market in 2023

Gummy supplements have grown in popularity as a convenient way to provide kids with the vitamins and minerals they require without having to consume a range of foods. Gummy supplements meet the changing demands of children. They supply comprehensive nourishment in an uncomplicated way to the kids. They are superior to normal vitamins and more appealing to capture kids' interest and make them easier to ingest. Unlike tablets or pills, gummies are easier for kids to swallow since they are shaped like sweets. Additionally, according to the scientific article titled “Intraindividual double burden of overweight and micronutrient deficiencies or anemia among preschool children”, published in 2020, an estimated 29% of preschool children worldwide are vitamin A deficient, 18% are anemic, and 17% are at danger of low zinc intake. Thus, the soaring rates of micronutrient deficiencies can be reduced with the help of gummy supplements, augmenting its market growth.

Make an Inquiry @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=39376426

North America region is witnessing the highest growth rate in the Gummy Supplements market

According to a 2022 report from the American Psychological Association, financial troubles, along with a deluge of horrible visuals from Ukraine as Russia, have pushed a majority of Americans to new levels of stress. Hence, although immunity gummies are increasingly popular in the US after the pandemic, interest in gummies that assist mental health and sleep has also been rising.

Additionally, according to the CDC,  the prevalence of metabolic syndrome is estimated at more than 30% in the United States Thus, A vitamin, mineral, or supplement product is normally taken by more than three out of every four Americans to maintain their health. Considering gummies are the most convenient and flavorful form of supplements providing a variety of functionality, the market is rapidly flourishing in this region.

[markettrend24]

CBD Nutraceuticals Market is Going to Boom |Gaia Botanicals, LLC, CV Sciences, Inc., Elixinol LLC, ENDOCA, Garden of Life, Green Roads

CBD Nutraceuticals Market is Going to Boom |Gaia Botanicals, LLC, CV Sciences, Inc., Elixinol LLC, ENDOCA, Garden of Life, Green Roads

CBD Nutraceuticals Market Size Analysis and Insights 2022: CBD NutraceuticalsMarket Report 2022, the business scene is covered from driving variables to upstream business sectors and the general condition of the market. An inside and out examination of the general development possibilities for the worldwide and regional market was given which depended on a top to bottom investigation of key…

[superbmilkshakemusic]

Medical Marijuana, Inc. Subsidiary HempMeds® Releases Broad-Spectrum CBD-Infused GummiesMJNA

Medical Marijuana, Inc. Subsidiary HempMeds® Releases Broad-Spectrum CBD-Infused GummiesMJNA

Medical Marijuana, Inc. Subsidiary HempMeds® Releases Broad-Spectrum CBD-Infused Gummies

Medical Marijuana, Inc. Subsidiary HempMeds® Releases Broad-Spectrum CBD-Infused Gummies

SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has released a brand new product to complement its extensive product line, broad-spectrum cannabidiol (CBD)-infused gummies.

HempMeds® gummies are gluten-free, vegan, and come in three delicious flavors: lime, strawberry and orange. Each jar contains 1,200mg of CBD broken down into sixty 20mg pieces. These gummies contain a proprietary blend of hemp oil as well as natural fruit flavor ingredients.

“As the cannabis industry evolves, so do the buying habits of our consumers and we want to be able to meet all of their needs,” said HempMeds® CEO Raul Elizalde. “We have always prioritized the feedback of our customers and we feel that these gummies are the next best addition to our growing line of Triple Lab Tested hemp-derived CBD products.”

According to a recent report by Grand View Research, the global CBD gummies market size was valued at USD 1.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 30.7% from 2021 to 2028.

“The popularity of CBD gummies has grown over the past year and doesn’t seem to be slowing down,” continued Elizalde. “We’ve crafted ours with the highest standards of safety and quality and instead of making them with CBD isolate like many of our competitors, we’ve made them with high-quality broad-spectrum CBD.”

To learn more about HempMeds® or purchase these products, please visit www.hempmedspx.com.

About HempMeds®Founded in 2012, HempMeds® was the first company to bring hemp-based cannabidiol (CBD) oil products to market in the U.S., Brazil and Mexico. As a subsidiary of Medical Marijuana, Inc., HempMeds® is the exclusive distributor for premium brands such as Real Scientific Hemp Oil™. The Company operates in all 50 states and throughout Latin America in countries such as Mexico, Brazil, Argentina, Paraguay and more. HempMeds® is one of the only companies to have its CBD products listed in the Prescribers’ Digital Reference (PDR), the only company invited to speak to the World Health Organization and FDA on the benefits of CBD, and one of the first to be certified by the U.S. Hemp Authority. To learn more, please visit www.hempmedspx.com.

Story continues

About Medical Marijuana, Inc.We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.

Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.

FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

CONTACT:

Public Relations Contact:Kathryn BrownAccount DirectorCMW MediaP. 858-264-6600kathryn@cmwmedia.comwww.cmwmedia.com

Investor Relations Contact:P. (858) 283-4016Investors@medicalmarijuanainc.com

Attachment

[market-insider]

Cannabis Cultivation Market Insights: Assessing Market Dynamics, Investment Opportunities, and Technological Advancements

The global cannabis cultivation market size is expected to reach USD 1,844.1 billion, expanding at a CAGR of 21.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing legalization and adoption of cannabis for the treatment of chronic diseases is positively impacting the market growth. Furthermore, the liberalization of laws related to hemp and marijuana by various countries is projected to further bolster revenue growth during the forecast period.

Cannabis Cultivation Market Report Highlights

The market is anticipated to witness significant growth owing to the growing legalization and adoption of hemp and marijuana for the treatment of chronic diseases

The hemp segment dominated the market in 2022, owing to the increasing adoption of hemp and derived products due to low THC content

The industrial consumption segment dominated the market in 2022, owing to the growing application of marijuana and hemp in various industries

In May 2022, Aurora Cannabis Inc. completed the purchase of TerraFarma Inc., which will contribute to their Canadian recreational cannabis company and Aurora's worldwide expertise in the cannabis market

In March 2022, HEXO and Tilray Brands Collaborate to Form Strategic Alliance, Uniting Two Canadian Cannabis Industry Leaders

In December 2021, As part of its continuous development plan, the Company purchased Quebec-based Laurentian Holdings Inc., boosting its presence in Quebec's second-most populated province

For More Details or Sample Copy please visit link @: Cannabis Cultivation Market Report

Furthermore, while the authorities imposed lockdown measures during COVID-19, European consumers hoarded supplies. Between January and March 2020, the value of items sold on Cannazon, a platform for hemp products, reached roughly USD 5.04 million reflecting a volume of 1.6 metric tonnes. In the U.S., a similar increase in sales was observed, with people stockpiling in anticipation of government-mandated shelters. As a result, increased stocks and strong consumer demand, as well as a growth in areas recognizing the product as a necessary commodity for recreational and medical uses, are projected to fuel market expansion throughout the forecast period.

Based on biomass, the hemp segment dominated the market in 2022. Factors contributing to increasing demand include the increasing adoption of hemp and derived products and its growing acceptance among users due to its low THC content. It is mainly used by people who intend to reap the medical benefits of the plant without getting intoxicated. In addition, positive government reforms regarding the utilization of hemp in many countries are further propelling market growth.

In 2022, the industrial consumption segment accounted for the highest revenue share. This growth is attributed to the growing application of marijuana and hemp in various industries such as pharmaceuticals, personal care & cosmetics, nutraceuticals, and food and beverages. In addition, the growing usage of cannabis and its derivatives as raw material by companies to produce their products is further fueling the growth. For instance, CBD oil and tinctures obtained from the plant are used by pharmaceutical companies for the production of cannabis-infused drugs. Hence, its consumption for various applications boosts the overall growth of the market.

Asia Pacific is expected to expand at the fastest CAGR in the forecast period owing to the presence of the largest cultivation markets in the region such as China, South Korea, India, and Australia. Furthermore, favorable climatic conditions, increasing awareness about the plant and its medical benefits, and a growing patient pool eligible for medical marijuana treatments are the other factors boosting the growth of the market in the region.

[pravalika]

Cannabidiol Market - Forecast (2022 - 2027)

Cannabidiol Market size is estimated to reach $93.4 billion by 2027, growing at a CAGR of 21.3% during the forecast period 2022-2027. Cannabidiol can be delineated as an active compound or phytocannabinoid derived from the flower and leaves of the cannabis Sativa plant. The cultivations of marijuana plants occur across the globe for medicinal purposes. Cannabidiol holds wide-ranging applications in the food and beverage industry, nutraceutical production, and treatment of several medical conditions such as neurogenerative disorder, diabetes, insomnia, stress, bone abnormalities, and many others. In addition to that, cannabidiol can help drug addicts to lower their cravings. As compared to hemp seeds oil which is fabricated from seeds only, CBD is a safer and more appropriate option. Also, Cannabidiol comes in a diversity of forms which include capsules, liquid, aerosol sprays. The cannabidiol market outlook is fairly fascinating as the demand for the product is enlarging year after year. Likewise, proliferating research and developmental activities, expanding drug distribution channel’s network, augmenting attentiveness among people regarding health benefits of cannabidiol, and heightening incidences of cancer, diabetes, neurological complications, stress, and bone abnormalities are factors set to drive the growth of the Cannabidiol Market for the period 2022-2027.

Request Sample

Report Coverage

The report: “Cannabidiol Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cannabidiol Market.

By Product Type: Full-Spectrum CBD oil, Broad-Spectrum Oil, and CBD isolate.

By Form: Capsule, Sprays, and Pure Liquid (Oil and Tinctures).

By Source: Hemp and Marijuana.

By Application: Medical treatments (Insomnia, Diabetes, Cancer, Neurological problems, Bone abnormalities, Migraine, and Others), Food and beverages, Nutraceutical, Personal care products, and Others.

By Distribution Channel: Offline (Retail Pharmacies, Hospital Pharmacies, and Others) and online.

By Geography:��North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

Geographically, the North America Cannabidiol Market accounted for the highest revenue share in 2021. The growth is owing to high health cognizance among residents compared to other parts of the world, lenient government policies regarding cannabis production for medical purposes, and the full-fledged pharmaceutical industry. Furthermore, Asia-Pacific is poised to dominate the market over the period 2022-2027.

Augmenting chronic applications and growing adoption of cannabidiol as health awareness among people is ascending and these factors said to be preeminent drivers driving the growth of the Cannabidiol Market. Crippled production and processing activities owing to pandemic restrictions and the exorbitant cost of cannabidiol are said to reduce the market growth.

Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Cannabidiol Market report.

Cannabidiol Market Segment Analysis-By Application

The Cannabidiol Market based on the applications can be further segmented into medical treatments (insomnia, diabetes, cancer, neurological problems, bone abnormalities, migraine, and others), food and beverages, nutraceutical, personal care products, and others. The medical treatments segment held the largest share in 2021. The growth is owing to ascending production of cannabidiol capsules, oils, and sprays as the demand for the product is sky-rocketing. Similarly, the medical treatments and nutraceutical segment is estimated to be the fastest-growing with a CAGR of 22.5% over the forecast period 2022-2027. This growth is owing to rising incidences of health problems like neurogenerative disorders, diabetes, cancer, joint dysfunctions, and many more. Sedentary habits, poor ingestions, and spiraling old-age population are the factors behind the unprecedented surge of such complications. In addition to that, a rising number of prevention-oriented individuals are making more demand for nutraceuticals to ensure proper nutrition intake. As a result, the demand for CBD in the said segments is escalating.

Inquiry Before Buying

Cannabidiol Market Segment Analysis-By Distribution Channel

The Cannabidiol Market based on distribution channels can be further segmented into offline (Retail pharmacies, hospital pharmacies, and others) and online. The offline segment held the largest share in 2021. The growth is owing to the across-the-board presence of retail pharmacies and hospitals. Institutions like hospitals are so well equipped that they offer a one-stop solution to patients; whereas, retail pharmacies offer convenient solutions to both chronic and acute problems as generally no prior prescription from a medical practitioner is required while making a purchase. Derisory infrastructure in squalid areas makes it hard for online pharmacies to offer their services; therefore, buying from offline platforms is the only option that people have. Furthermore, the offline segment is estimated to be the fastest-growing with a CAGR of 22.8% over the forecast period 2022-2027. Unlike, online platforms, in retail or hospital pharmacies it is easy to explain health problems to doctors or pharmacists. On another hand, buying from online pharmacies may be easy but it requires proper understanding about “what type of medicine you are looking for? whereas, in an offline purchase, if the patient might give a little clue, the medical practitioner suggests the best possible solution according to their knowledge, which is comparatively easy.

Schedule a Call

Cannabidiol Market Segment Analysis-By Geography

The Cannabidiol Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 40% of the overall market in 2021. The growth in this segment is owing to the factors such as heavy investment in research and development activities compared to any other continent on planet earth. Besides, high health cognizance among people, presence of world-class healthcare infrastructure, leading pharmaceutical companies, and high disposable income of people which allows them to pay a high price for cannabidiol are the factors providing growth opportunities. However, Asia-Pacific is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to rising chronic pain incidences as the geriatric population in Japan and China is augmenting steadily. Besides, sky-rocketing pharmaceutical industry as India is a leading generic drug manufacturer whereas China is the leading API manufacturer in the world.

Cannabidiol Market Drivers

Proliferating chronic conditions are anticipated to boost market demand.

Intensifying chronic stress prevalence has heightened the occurrence of various neurodegenerative disorders such as Parkinson’s and Alzheimer’s in both developing and developed countries. A WHO report claimed that over 55 million people across the globe were living with dementia last year. Moreover, according to a report by Alzheimer’s Association, in 2021 more than 6 million American geriatrics were inflicted with dementia. Cancer is the 2nd biggest reason behind deaths on planet earth; whereas, from 10.5 percent in 2021, it is anticipated that around 12-13 percent of the world population will suffer from diabetes by 2045.

Rising demand for Cannabidiol from cosmetics is expected to boost market demand.

The expanding demand for cannabis-based cosmetic products as people especially youngsters is becoming more look-oriented. Today body dysmorphic disorder is one of the biggest reasons behind growing stress and anxiety among teenagers. According to a WHO report, around 1 in 7 adolescents aged above 10 years have mental problems because of stress and depression. The growing obsession of youngsters regarding their looks is indeed a blessing in disguise for the growth of the aforementioned market as it is augmenting the demand for personal care products.

Buy Now

Cannabidiol Market Challenges

Extortionate price and hampered production because of the COVID-19 are Anticipated to hamper the market growth.

The price of cannabidiol is a bit on the dear side as just one gram of it can up to $60. Therefore, the expensive nature of the product can pose a challenge to the growth of the aforementioned market. Moreover, the production and processing activities have taken a huge hit after a year-long lockdown. Also, with growing mutations in virus structure, governments worldwide are reconsidering certain constraints to control the virus spread which can lead to a big mismatch between demand and supply chain.

Cannabidiol Market Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the aforementioned Market. Cannabidiol market top 10 companies include:

Elixinol LLC

NuLeaf Naturals

ENDOCA

Cannoid LLC

Medical Marijuana

Folium Biosciences

Isodiol International

Arena International

 VIVO Cannabis

Dixie Brands

Recent Developments

On December 21, 2021, New York, United States-based multinational pharma and biopharmaceutical company “Pfizer” announced that the company will soon acquire California, United States-based Arena Pharmaceutical (a company known for its cannabis-based therapeutics). Pfizer agreed to pay $6.7 billion ($100 per share) to bring the acquisition to a close. The transaction will enhance Pfizer’s expertise in the cannabis-based treatment of bowel disease.

On November 29, 2021, Alberta, Canada-based cannabis company “High Tide” announced that it has acquired Colorado, United States-based well-known cannabis firm “NuLeaf Naturals.” A payment of $31 million was paid by High Tide to buy 80 percent of the ownership interest. The transaction has further strengthened the retail business of High Tide.

On March 18, 2021, Australia-based cannabis company Elixinol (a firm known for its CBD hemp oil) announced the successful acquisition of Hamburg, Germany-based vitamin and supplement company “CannaCare Health.” Payment of a total of 9 million euros (3 million cash and 6 million shares) was made by Elixinol to bring the acquisition to a close.

For more Food and Beverage Market related reports, please click here

[teeresearch]

Cannabidiol Market - Forecast (2022 - 2027)

Cannabidiol Market Overview

Cannabidiol Market size is estimated to reach $93.4 billion by 2027, growing at a CAGR of 21.3% during the forecast period 2022-2027. Cannabidiol can be delineated as an active compound or phytocannabinoid derived from the flower and leaves of the cannabis Sativa plant. The cultivations of marijuana plants occur across the globe for medicinal purposes. Cannabidiol holds wide-ranging applications in the food and beverage industry, nutraceutical production, and treatment of several medical conditions such as neurogenerative disorder, diabetes, insomnia, stress, bone abnormalities, and many others. In addition to that, cannabidiol can help drug addicts to lower their cravings. As compared to hemp seeds oil which is fabricated from seeds only, CBD is a safer and more appropriate option. Also, Cannabidiol comes in a diversity of forms which include capsules, liquid, aerosol sprays. The cannabidiol market outlook is fairly fascinating as the demand for the product is enlarging year after year. Likewise, proliferating research and developmental activities, expanding drug distribution channel’s network, augmenting attentiveness among people regarding health benefits of cannabidiol, and heightening incidences of cancer, diabetes, neurological complications, stress, and bone abnormalities are factors set to drive the growth of the Cannabidiol Market for the period 2022-2027.

Report Coverage

The report: “Cannabidiol Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cannabidiol Market.

By Product Type: Full-Spectrum CBD oil, Broad-Spectrum Oil, and CBD isolate.

By Form: Capsule, Sprays, and Pure Liquid (Oil and Tinctures).

By Source: Hemp and Marijuana.

By Application: Medical treatments (Insomnia, Diabetes, Cancer, Neurological problems, Bone abnormalities, Migraine, and Others), Food and beverages, Nutraceutical, Personal care products, and Others.

By Distribution Channel: Offline (Retail Pharmacies, Hospital Pharmacies, and Others) and online.

By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).

Inquiry Before Buying

Key Takeaways

Geographically, the North America Cannabidiol Market accounted for the highest revenue share in 2021. The growth is owing to high health cognizance among residents compared to other parts of the world, lenient government policies regarding cannabis production for medical purposes, and the full-fledged pharmaceutical industry. Furthermore, Asia-Pacific is poised to dominate the market over the period 2022-2027.

Augmenting chronic applications and growing adoption of cannabidiol as health awareness among people is ascending and these factors said to be preeminent drivers driving the growth of the Cannabidiol Market. Crippled production and processing activities owing to pandemic restrictions and the exorbitant cost of cannabidiol are said to reduce the market growth.

Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Cannabidiol Market report.

Cannabidiol Market Segment Analysis-By Application

The Cannabidiol Market based on the applications can be further segmented into medical treatments (insomnia, diabetes, cancer, neurological problems, bone abnormalities, migraine, and others), food and beverages, nutraceutical, personal care products, and others. The medical treatments segment held the largest share in 2021. The growth is owing to ascending production of cannabidiol capsules, oils, and sprays as the demand for the product is sky-rocketing. Similarly, the medical treatments and nutraceutical segment is estimated to be the fastest-growing with a CAGR of 22.5% over the forecast period 2022-2027. This growth is owing to rising incidences of health problems like neurogenerative disorders, diabetes, cancer, joint dysfunctions, and many more. Sedentary habits, poor ingestions, and spiraling old-age population are the factors behind the unprecedented surge of such complications. In addition to that, a rising number of prevention-oriented individuals are making more demand for nutraceuticals to ensure proper nutrition intake. As a result, the demand for CBD in the said segments is escalating.

Request Sample

Cannabidiol Market Segment Analysis-By Distribution Channel

The Cannabidiol Market based on distribution channels can be further segmented into offline (Retail pharmacies, hospital pharmacies, and others) and online. The offline segment held the largest share in 2021. The growth is owing to the across-the-board presence of retail pharmacies and hospitals. Institutions like hospitals are so well equipped that they offer a one-stop solution to patients; whereas, retail pharmacies offer convenient solutions to both chronic and acute problems as generally no prior prescription from a medical practitioner is required while making a purchase. Derisory infrastructure in squalid areas makes it hard for online pharmacies to offer their services; therefore, buying from offline platforms is the only option that people have. Furthermore, the offline segment is estimated to be the fastest-growing with a CAGR of 22.8% over the forecast period 2022-2027. Unlike, online platforms, in retail or hospital pharmacies it is easy to explain health problems to doctors or pharmacists. On another hand, buying from online pharmacies may be easy but it requires proper understanding about “what type of medicine you are looking for? whereas, in an offline purchase, if the patient might give a little clue, the medical practitioner suggests the best possible solution according to their knowledge, which is comparatively easy.

Cannabidiol Market Segment Analysis-By Geography

The Cannabidiol Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 40% of the overall market in 2021. The growth in this segment is owing to the factors such as heavy investment in research and development activities compared to any other continent on planet earth. Besides, high health cognizance among people, presence of world-class healthcare infrastructure, leading pharmaceutical companies, and high disposable income of people which allows them to pay a high price for cannabidiol are the factors providing growth opportunities. However, Asia-Pacific is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to rising chronic pain incidences as the geriatric population in Japan and China is augmenting steadily. Besides, sky-rocketing pharmaceutical industry as India is a leading generic drug manufacturer whereas China is the leading API manufacturer in the world.

Schedule a Call

Cannabidiol Market Drivers

Proliferating chronic conditions are anticipated to boost market demand.

Intensifying chronic stress prevalence has heightened the occurrence of various neurodegenerative disorders such as Parkinson’s and Alzheimer’s in both developing and developed countries. A WHO report claimed that over 55 million people across the globe were living with dementia last year. Moreover, according to a report by Alzheimer’s Association, in 2021 more than 6 million American geriatrics were inflicted with dementia. Cancer is the 2nd biggest reason behind deaths on planet earth; whereas, from 10.5 percent in 2021, it is anticipated that around 12-13 percent of the world population will suffer from diabetes by 2045.

Rising demand for Cannabidiol from cosmetics is expected to boost market demand.

The expanding demand for cannabis-based cosmetic products as people especially youngsters is becoming more look-oriented. Today body dysmorphic disorder is one of the biggest reasons behind growing stress and anxiety among teenagers. According to a WHO report, around 1 in 7 adolescents aged above 10 years have mental problems because of stress and depression. The growing obsession of youngsters regarding their looks is indeed a blessing in disguise for the growth of the aforementioned market as it is augmenting the demand for personal care products.

Cannabidiol Market Challenges

Extortionate price and hampered production because of the COVID-19 are Anticipated to hamper the market growth.

The price of cannabidiol is a bit on the dear side as just one gram of it can up to $60. Therefore, the expensive nature of the product can pose a challenge to the growth of the aforementioned market. Moreover, the production and processing activities have taken a huge hit after a year-long lockdown. Also, with growing mutations in virus structure, governments worldwide are reconsidering certain constraints to control the virus spread which can lead to a big mismatch between demand and supply chain.

Buy Now

Cannabidiol Market Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the aforementioned Market.

Cannabidiol market top 10 companies include:

Elixinol LLC

NuLeaf Naturals

ENDOCA

Cannoid LLC

Medical Marijuana

Folium Biosciences

Isodiol International

Arena International

 VIVO Cannabis

Dixie Brands

Recent Developments

On December 21, 2021, New York, United States-based multinational pharma and biopharmaceutical company “Pfizer” announced that the company will soon acquire California, United States-based Arena Pharmaceutical (a company known for its cannabis-based therapeutics). Pfizer agreed to pay $6.7 billion ($100 per share) to bring the acquisition to a close. The transaction will enhance Pfizer’s expertise in the cannabis-based treatment of bowel disease.

On November 29, 2021, Alberta, Canada-based cannabis company “High Tide” announced that it has acquired Colorado, United States-based well-known cannabis firm “NuLeaf Naturals.” A payment of $31 million was paid by High Tide to buy 80 percent of the ownership interest. The transaction has further strengthened the retail business of High Tide.

On March 18, 2021, Australia-based cannabis company Elixinol (a firm known for its CBD hemp oil) announced the successful acquisition of Hamburg, Germany-based vitamin and supplement company “CannaCare Health.” Payment of a total of 9 million euros (3 million cash and 6 million shares) was made by Elixinol to bring the acquisition to a close.

For more Food and Beverage Market related reports, please click here

[ananya5400]

Gummy Supplement Market Projected to Garner Significant Revenues by 2028

According to a research report "Gummy Supplements Market by Type (Vitamin Gummies, Omega Fatty Acid Gummies, Collagen Gummies, CBD Gummies), Starch Ingredient (Supplements With Starch, Starchless Systems), Distribution Channel, End User, Functionality & Region - Global Forecast to 2028" published by MarketsandMarkets, the global Gummy supplement market is projected to reach USD 48.5 billion by 2028 from USD 24.6 billion by 2023, at a CAGR of 14.5% during the forecast period in terms of value. The World Health Organization (WHO) estimates that more than two billion people worldwide suffer from micronutrient insufficiency. Iron, vitamin A, and iodine deficiencies are the most prevalent worldwide, particularly in youngsters and pregnant women. Micronutrient deficits are disproportionately prevalent in low- and middle-income counties. Micronutrient deficiencies can induce evident and serious health issues, but they can also produce less clinically noticeable decreases in energy, mental clarity, and overall capacity. This may result in poorer academic performance, decreased productivity at work, and a higher chance of contracting other illnesses and medical disorders. A lot of these inadequacies can be avoided by taking supplements. Thus, consumers are gradually adopting gummy supplements which provide the required number of vitamins, minerals, and other micronutrients in a convenient and tasteful form.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39376426

Vitamin gummies segment is anticipated to have the largest share among gummy types in 2023

The global market for gummy vitamins is currently experiencing tremendous growth. Gummy vitamins typically have delicious fruity flavors and all the necessary micronutrients. Therefore, a lot of individuals choose gummy vitamins over conventional vitamins, especially kids and elder people who have problems swallowing tablets. In the upcoming years, the nutraceutical business is expected to see a significant increase in sales of vitamin gummies. Working-class consumers who seek to balance health factors like folic acid, metabolic health, and glycemic index in an effort to address problems like bone strength, immunity, and vitamin deficiencies will also contribute significantly in the expansion of the gummy supplements market.

The kids segment is projected to grow at the fastest rate among all the other end-users in the Gummy Supplements market in 2023

Gummy supplements have grown in popularity as a convenient way to provide kids with the vitamins and minerals they require without having to consume a range of foods. Gummy supplements meet the changing demands of children. They supply comprehensive nourishment in an uncomplicated way to the kids. They are superior to normal vitamins and more appealing to capture kids' interest and make them easier to ingest. Unlike tablets or pills, gummies are easier for kids to swallow since they are shaped like sweets. Additionally, according to the scientific article titled “Intraindividual double burden of overweight and micronutrient deficiencies or anemia among preschool children”, published in 2020, an estimated 29% of preschool children worldwide are vitamin A deficient, 18% are anemic, and 17% are at danger of low zinc intake. Thus, the soaring rates of micronutrient deficiencies can be reduced with the help of gummy supplements, augmenting its market growth.

Make an Inquiry @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=39376426

North America region is witnessing the highest growth rate in the Gummy Supplements market

According to a 2022 report from the American Psychological Association, financial troubles, along with a deluge of horrible visuals from Ukraine as Russia, have pushed a majority of Americans to new levels of stress. Hence, although immunity gummies are increasingly popular in the US after the pandemic, interest in gummies that assist mental health and sleep has also been rising.

Additionally, according to the CDC,  the prevalence of metabolic syndrome is estimated at more than 30% in the United States Thus, A vitamin, mineral, or supplement product is normally taken by more than three out of every four Americans to maintain their health. Considering gummies are the most convenient and flavorful form of supplements providing a variety of functionality, the market is rapidly flourishing in this region.

[manideep8]

Cannabidiol Market - Forecast (2022 - 2027)

Cannabidiol Market size is estimated to reach $93.4 billion by 2027, growing at a CAGR of 21.3% during the forecast period 2022-2027. Cannabidiol can be delineated as an active compound or phytocannabinoid derived from the flower and leaves of the cannabis Sativa plant. The cultivations of marijuana plants occur across the globe for medicinal purposes. Cannabidiol holds wide-ranging applications in the food and beverage industry, nutraceutical production, and treatment of several medical conditions such as neurogenerative disorder, diabetes, insomnia, stress, bone abnormalities, and many others. In addition to that, cannabidiol can help drug addicts to lower their cravings. As compared to hemp seeds oil which is fabricated from seeds only, CBD is a safer and more appropriate option. Also, Cannabidiol comes in a diversity of forms which include capsules, liquid, aerosol sprays. The cannabidiol market outlook is fairly fascinating as the demand for the product is enlarging year after year. Likewise, proliferating research and developmental activities, expanding drug distribution channel’s network, augmenting attentiveness among people regarding health benefits of cannabidiol, and heightening incidences of cancer, diabetes, neurological complications, stress, and bone abnormalities are factors set to drive the growth of the Cannabidiol Market for the period 2022-2027.

Report Coverage

The Report : “Cannabidiol Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cannabidiol Market.

By Product Type : Full-Spectrum CBD oil, Broad-Spectrum Oil, and CBD isolate.By Form : Capsule, Sprays, and Pure Liquid (Oil and Tinctures).

By Source : Hemp and Marijuana.By Application : Medical treatments (Insomnia, Diabetes, Cancer, Neurological problems, Bone abnormalities, Migraine, and Others), Food and beverages, Nutraceutical, Personal care products, and Others.

By Distribution Channel : Offline (Retail Pharmacies, Hospital Pharmacies, and Others) and online.

By Geography : North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).

Inquiry Before Buying : https://www.industryarc.com/reports/request-quote?id=19651

Key Takeaways

Geographically, the North America Cannabidiol Market accounted for the highest revenue share in 2021. The growth is owing to high health cognizance among residents compared to other parts of the world, lenient government policies regarding cannabis production for medical purposes, and the full-fledged pharmaceutical industry. Furthermore, Asia-Pacific is poised to dominate the market over the period 2022-2027.

Augmenting chronic applications and growing adoption of cannabidiol as health awareness among people is ascending and these factors said to be preeminent drivers driving the growth of the Cannabidiol Market. Crippled production and processing activities owing to pandemic restrictions and the exorbitant cost of cannabidiol are said to reduce the market growth.

Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Cannabidiol Market report.

Request For Sample : https://www.industryarc.com/pdfdownload.php?id=19651

Cannabidiol Market Segment Analysis-By Application

The Cannabidiol Market based on the applications can be further segmented into medical treatments (insomnia, diabetes, cancer, neurological problems, bone abnormalities, migraine, and others), food and beverages, nutraceutical, personal care products, and others. The medical treatments segment held the largest share in 2021. The growth is owing to ascending production of cannabidiol capsules, oils, and sprays as the demand for the product is sky-rocketing. Similarly, the medical treatments and nutraceutical segment is estimated to be the fastest-growing with a CAGR of 22.5% over the forecast period 2022-2027. This growth is owing to rising incidences of health problems like neurogenerative disorders, diabetes, cancer, joint dysfunctions, and many more. Sedentary habits, poor ingestions, and spiraling old-age population are the factors behind the unprecedented surge of such complications. In addition to that, a rising number of prevention-oriented individuals are making more demand for nutraceuticals to ensure proper nutrition intake. As a result, the demand for CBD in the said segments is escalating.

Cannabidiol Market Segment Analysis-By Distribution Channel

The Cannabidiol Market based on distribution channels can be further segmented into offline (Retail pharmacies, hospital pharmacies, and others) and online. The offline segment held the largest share in 2021. The growth is owing to the across-the-board presence of retail pharmacies and hospitals. Institutions like hospitals are so well equipped that they offer a one-stop solution to patients; whereas, retail pharmacies offer convenient solutions to both chronic and acute problems as generally no prior prescription from a medical practitioner is required while making a purchase. Derisory infrastructure in squalid areas makes it hard for online pharmacies to offer their services; therefore, buying from offline platforms is the only option that people have. Furthermore, the offline segment is estimated to be the fastest-growing with a CAGR of 22.8% over the forecast period 2022-2027. Unlike, online platforms, in retail or hospital pharmacies it is easy to explain health problems to doctors or pharmacists. On another hand, buying from online pharmacies may be easy but it requires proper understanding about “what type of medicine you are looking for? whereas, in an offline purchase, if the patient might give a little clue, the medical practitioner suggests the best possible solution according to their knowledge, which is comparatively easy.

Cannabidiol Market Segment Analysis-By Geography

The Cannabidiol Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 40% of the overall market in 2021. The growth in this segment is owing to the factors such as heavy investment in research and development activities compared to any other continent on planet earth. Besides, high health cognizance among people, presence of world-class healthcare infrastructure, leading pharmaceutical companies, and high disposable income of people which allows them to pay a high price for cannabidiol are the factors providing growth opportunities. However, Asia-Pacific is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to rising chronic pain incidences as the geriatric population in Japan and China is augmenting steadily. Besides, sky-rocketing pharmaceutical industry as India is a leading generic drug manufacturer whereas China is the leading API manufacturer in the world.

Cannabidiol Market Drivers

Proliferating chronic conditions are anticipated to boost market demand.

Intensifying chronic stress prevalence has heightened the occurrence of various neurodegenerative disorders such as Parkinson’s and Alzheimer’s in both developing and developed countries. A WHO report claimed that over 55 million people across the globe were living with dementia last year. Moreover, according to a report by Alzheimer’s Association, in 2021 more than 6 million American geriatrics were inflicted with dementia. Cancer is the 2nd biggest reason behind deaths on planet earth; whereas, from 10.5 percent in 2021, it is anticipated that around 12-13 percent of the world population will suffer from diabetes by 2045.

Rising demand for Cannabidiol from cosmetics is expected to boost market demand.

The expanding demand for cannabis-based cosmetic products as people especially youngsters is becoming more look-oriented. Today body dysmorphic disorder is one of the biggest reasons behind growing stress and anxiety among teenagers. According to a WHO report, around 1 in 7 adolescents aged above 10 years have mental problems because of stress and depression. The growing obsession of youngsters regarding their looks is indeed a blessing in disguise for the growth of the aforementioned market as it is augmenting the demand for personal care products.

Cannabidiol Market Challenges

Extortionate price and hampered production because of the COVID-19 are Anticipated to hamper the market growth.

The price of cannabidiol is a bit on the dear side as just one gram of it can up to $60. Therefore, the expensive nature of the product can pose a challenge to the growth of the aforementioned market. Moreover, the production and processing activities have taken a huge hit after a year-long lockdown. Also, with growing mutations in virus structure, governments worldwide are reconsidering certain constraints to control the virus spread which can lead to a big mismatch between demand and supply chain.

Buy Now : https://www.industryarc.com/purchasereport.php?id=19651

Cannabidiol Market Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the aforementioned Market. Cannabidiol market top 10 companies include:

Elixinol LLC

NuLeaf Naturals

ENDOCA

Cannoid LLC

Medical Marijuana

Folium Biosciences

Isodiol International

Arena International

VIVO Cannabis

Dixie Brands

Recent Developments

On December 21, 2021, New York, United States-based multinational pharma and biopharmaceutical company “Pfizer” announced that the company will soon acquire California, United States-based Arena Pharmaceutical (a company known for its cannabis-based therapeutics). Pfizer agreed to pay $6.7 billion ($100 per share) to bring the acquisition to a close. The transaction will enhance Pfizer’s expertise in the cannabis-based treatment of bowel disease.

On November 29, 2021, Alberta, Canada-based cannabis company “High Tide” announced that it has acquired Colorado, United States-based well-known cannabis firm “NuLeaf Naturals.” A payment of $31 million was paid by High Tide to buy 80 percent of the ownership interest. The transaction has further strengthened the retail business of High Tide.

On March 18, 2021, Australia-based cannabis company Elixinol (a firm known for its CBD hemp oil) announced the successful acquisition of Hamburg, Germany-based vitamin and supplement company “CannaCare Health.” Payment of a total of 9 million euros (3 million cash and 6 million shares) was made by Elixinol to bring the acquisition to a close.

Relevant Links:

Alzheimer Drugs Market – Forecast (2022 - 2027)

Report Code: HCR 0112

Hemp CBD Market – Forecast (2022 - 2027)

Report Code: HCR 1418

Industrial Hemp Market-Forecast (2021 – 2026)

Report Code: CMR 45256

For more Food and Beverage Market related reports, please

click here